Pore size-mediated macrophage M1-to-M2 transition influences new vessel formation within the compartment of a scaffold
Source abstract
Abstract
Abstract Increasing evidence indicates that material pore size can affect both macrophage (Mφ) polarization and new vessel formation within the compartment of a transplant. Using genipin cross-linked collagen/chitosan (Col-Ch) scaffolds with average pore sizes of 160 and 360 μm (Col-Ch-160 and Col-Ch-360, respectively) as material vascularization models, this study examined the influence of pore size-mediated M1-to-M2 transition of Mφs penetrating the scaffold on subsequent angiogenesis and vascularization. Following seeding in scaffolds, Mφs (M0 or M1) on both scaffolds tended to exhibit the M1 phenotype at day 1 and the M2 phenotype at day 3 and day 7. Col-Ch-360 exhibited a greater potential to encourage M1-to-M2 transition and to promote Mφ secretion of anti-inflammatory and pro-angiogenic cytokines. When supernatants derived from Mφ-scaffold cultures were used to incubate human umbilical vein endothelial cells (HUVECs), cells incubated with Col-Ch-360-derived supernatants displayed a great angiogenic response in terms of tube formation and cell migration. Compared with Col-Ch-160, subcutaneous transplantation of Col-Ch-360 scaffolds resulted in more blood vessel formation, along with more VEGF+ cells and fewer pro-inflammatory (M1) Mφs across the pores of the material. Our data suggest that compared to Col-Ch-160, Col-Ch-360 scaffolds promote angiogenesis in vitro and vascularization in vivo, most likely because Mφs residing in materials with larger pores undergo a higher degree of M1-to-M2 transition.
Source: openaire · Quality: candidate unverified · Source record ↗
Research context
OpenAlex topics: Immune cells in cancer · Angiogenesis and VEGF in Cancer · Tissue Engineering and Regenerative Medicine
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (77)
Show source-provided references
1. Novel advances in the design of three-dimensional bio-scaffolds to control cell fate: translation from 2D to 3D10.1016/j.tibtech.2012.03.005 ↗
2. 3D biofabrication strategies for tissue engineering and regenerative medicine10.1146/annurev-bioeng-071813-105155 ↗
3. 3D-printed scaffolds with synergistic effect of hollow-pipe structure and bioactive ions for vascularized bone regeneration10.1016/j.biomaterials.2017.05.005 ↗
4. Physical approaches to biomaterial design10.1038/nmat2344 ↗
5. Porous and sutureless bioelectronic patch with retained electronic properties under cyclic stretching10.1016/j.apmt.2019.02.013 ↗
6. Optimally porous and biomechanically compatible scaffolds for large-area bone regeneration10.1089/ten.tea.2011.0076 ↗
7. Chitosan scaffolds: interconnective pore size and cartilage engineering10.1016/j.actbio.2005.12.007 ↗
8. Vascularization in craniofacial bone tissue engineering10.1177/0022034518767120 ↗
9. The role of pore size on vascularization and tissue remodeling in PEG hydrogels10.1016/j.biomaterials.2011.04.066 ↗
10. Neovascularization in biodegradable inverse opal scaffolds with uniform and precisely controlled pore sizes10.1002/adhm.201200106 ↗
11. The correlation between the internal structure and vascularization of controllable porous bioceramic materials in vivo: a quantitative study10.1089/ten.tea.2010.0148 ↗
12. Osteal macrophages promote in vivo intramembranous bone healing in a mouse tibial injury model10.1002/jbmr.354 ↗
13. Regulation of angiogenesis, mural cell recruitment and adventitial macrophage behavior by toll-like receptors10.1007/s10456-013-9384-3 ↗
14. Monocyte and macrophage plasticity in tissue repair and regeneration10.1016/j.ajpath.2015.06.001 ↗
15. Soluble mediators produced by pro-resolving macrophages inhibit angiogenesis10.3389/fimmu.2018.00768 ↗
16. Promoting in vivo early angiogenesis with sub-micrometer strontium-contained bioactive microspheres through modulating macrophage phenotypes10.1016/j.biomaterials.2018.06.004 ↗
17. Macrophages commit postnatal endothelium-derived progenitors to angiogenesis and restrict endothelial to mesenchymal transition during muscle regeneration10.1038/cddis.2013.558 ↗
18. Rethinking regenerative medicine: a macrophage-centered approach10.3389/fimmu.2014.00510 ↗
19. Alternatively activated macrophages in infection and autoimmunity10.1016/j.jaut.2009.09.012 ↗
20. Macrophage polarization: tumor-associated macrophages as a paradigm for polarized M2 mononuclear phagocytes10.1016/S1471-4906(02)02302-5 ↗
21. Role of monocytes and macrophages in angiogenesis
22. The role of macrophage phenotype in vascularization of tissue engineering scaffolds10.1016/j.biomaterials.2014.02.012 ↗
23. The effect of thick fibers and large pores of electrospun poly(epsilon-caprolactone) vascular grafts on macrophage polarization and arterial regeneration10.1016/j.biomaterials.2014.03.078 ↗
24. Mechanisms of organ injury and repair by macrophages10.1146/annurev-physiol-022516-034356 ↗
25. Sequential delivery of immunomodulatory cytokines to facilitate the M1-to-M2 transition of macrophages and enhance vascularization of bone scaffolds10.1016/j.biomaterials.2014.10.017 ↗
26. Physical and mechanical regulation of macrophage phenotype and function10.1007/s00018-014-1796-8 ↗
27. Nanoporous microstructures mediate osteogenesis by modulating the osteo-immune response of macrophages10.1039/C6NR06421C ↗
28. Macrophage functional polarization (M1/M2) in response to varying fiber and pore dimensions of electrospun scaffolds10.1016/j.biomaterials.2013.02.065 ↗
29. Porous implants modulate healing and induce shifts in local macrophage polarization in the foreign body reaction10.1007/s10439-013-0933-0 ↗
30. Tailoring the pore architecture in 3-D alginate scaffolds by controlling the freezing regime during fabrication10.1016/S0142-9612(02)00146-1 ↗
31. Differentiation of bone marrow stromal cells in poly(lactide-co-glycolide)/chitosan scaffolds10.1016/j.biomaterials.2009.08.028 ↗
32. Engineering a morphogenetically active hydrogel for bioprinting of bioartificial tissue derived from human osteoblast-like SaOS-2 cells10.1016/j.biomaterials.2014.07.002 ↗
33. Modular small diameter vascular grafts with bioactive functionalities10.1371/journal.pone.0133632 ↗
34. The effects of conditioned media generated by polarized macrophages on the cellular behaviours of bone marrow mesenchymal stem cells10.1111/jcmm.13431 ↗
35. Influences of age-related changes in mesenchymal stem cells on macrophages during in-vitro culture10.1186/s13287-017-0608-0 ↗
36. In vitro scratch assay: a convenient and inexpensive method for analysis of cell migration in vitro10.1038/nprot.2007.30 ↗
37. TGF-beta1 enhances SDF-1-induced migration and tube formation of choroid-retinal endothelial cells by up-regulating CXCR4 and CXCR7 expression10.1007/s11010-014-2180-6 ↗
38. The effect of pore size on tissue ingrowth and neovascularization in porous bioceramics of controlled architecture in vivo10.1088/1748-6041/6/1/015007 ↗
39. Engineering vascular tissue with functional smooth muscle cells derived from human iPS cells and nanofibrous scaffolds10.1016/j.biomaterials.2014.07.011 ↗
40. The collagen family10.1101/cshperspect.a004978 ↗
41. Chitosan as a starting material for wound healing applications10.1016/j.ejpb.2015.08.004 ↗
42. Phosphocreatine-modified chitosan porous scaffolds promote mineralization and osteogenesis in vitro and in vivo10.1016/j.apmt.2018.03.010 ↗
43. Crosslinking strategies for preparation of extracellular matrix-derived cardiovascular scaffolds10.1093/rb/rbu009 ↗
44. Influence of freezing rate on pore structure in freeze-dried collagen-GAG scaffolds10.1016/S0142-9612(03)00630-6 ↗
45. Pore architecture and cell viability on freeze dried 3D recombinant human collagen-peptide (RHC)-chitosan scaffolds10.1016/j.msec.2014.12.076 ↗
46. Macrophage involvement affects matrix stiffness-related influences on cell osteogenesis under three-dimensional culture conditions10.1016/j.actbio.2018.02.015 ↗
47. Fabrication and characterization of chitosan-hyaluronic acid scaffolds with varying stiffness for glioblastoma cell culture10.1002/adhm.201800295 ↗
48. Tunable stiffness of graphene oxide/polyacrylamide composite scaffolds regulates cytoskeleton assembly10.1039/C8SC02100G ↗
49. Matrix stiffness modulates the differentiation of neural crest stem cells in vivo10.1002/jcp.27518 ↗
50. Innate immune responses of primary murine macrophage-lineage cells and RAW 264.7 cells to ligands of Toll-like receptors 2, 3, and 410.1016/j.cimid.2009.07.001 ↗
51. Modulating macrophage responses to promote tissue regeneration by changing the formulation of bone extracellular matrix from filler particles to gel bioscaffolds10.1016/j.msec.2019.03.107 ↗
52. Macrophages in tissue repair, regeneration, and fibrosis10.1016/j.immuni.2016.02.015 ↗
53. Macrophages in skin injury and repair10.1016/j.imbio.2011.01.001 ↗
54. The IL-6-soluble IL-6Ralpha autocrine loop of endothelial activation as an intermediate between acute and chronic inflammation: an experimental model involving thrombin10.4049/jimmunol.167.6.3435 ↗
55. Anti-inflammatory M2, but not pro-inflammatory M1 macrophages promote angiogenesis in vivo10.1007/s10456-013-9381-6 ↗
56. Production of vascular endothelial growth factor by murine macrophages: regulation by hypoxia, lactate, and the inducible nitric oxide synthase pathway10.1016/S0002-9440(10)65601-5 ↗
57. The effect of biomaterials used for tissue regeneration purposes on polarization of macrophages10.1089/biores.2015.0041 ↗
58. Macrophages: plastic solutions to environmental heterogeneity10.1007/s00011-013-0647-7 ↗
59. Tissue myeloid progenitors differentiate into pericytes through TGF-beta signaling in developing skin vasculature10.1016/j.celrep.2017.02.069 ↗
60. Macrophage-derived angiogenesis factors10.1016/0163-7258(91)90077-Y ↗
61. IL-6 in human cytomegalovirus secretome promotes angiogenesis and survival of endothelial cells through the stimulation of survivin10.1182/blood-2010-06-291245 ↗
62. Spatiotemporal control over growth factor signaling for therapeutic neovascularization10.1016/j.addr.2007.08.012 ↗
63. IL-1 is required for tumor invasiveness and angiogenesis10.1073/pnas.0437939100 ↗
64. Macrophages and angiogenesis10.1002/jlb.55.3.410 ↗
65. IL-10 inhibits inflammation and attenuates left ventricular remodeling after myocardial infarction via activation of STAT3 and suppression of HuR10.1161/CIRCRESAHA.108.188243 ↗
66. Disruption of TGF-beta signaling in smooth muscle cell prevents flow-induced vascular remodeling10.1016/j.bbrc.2014.10.092 ↗
67. Production of transforming growth factor beta 1 during repair of arterial injury10.1172/JCI115393 ↗
68. Mechanisms of vessel regression: toward an understanding of the resolution of angiogenesis
69. Immunomodulatory application of engineered hydrogels in regenerative medicine10.1016/j.apmt.2018.11.013 ↗
70. Enhanced angiogenesis of biodegradable iron-doped octacalcium phosphate/poly(lactic-co-glycolic acid) scaffold for potential cancerous bone regeneration10.1016/j.apmt.2019.01.002 ↗
71. The biology of VEGF and its receptors10.1038/nm0603-669 ↗
72. Angiogenesis in health and disease10.1038/nm0603-653 ↗
73. Angiogenesis and chronic inflammation: cause or consequence?10.1007/s10456-007-9074-0 ↗
74. Three-dimensional scaffolds for tissue engineering applications: role of porosity and pore size10.1089/ten.teb.2012.0437 ↗
75. CD206(+) M2-like macrophages regulate systemic glucose metabolism by inhibiting proliferation of adipocyte progenitors10.1038/s41467-017-00231-1 ↗
76. CCR7 maintains nonresolving lymph node and adipose inflammation in obesity10.2337/db15-1689 ↗
77. Understanding the mysterious M2 macrophage through activation markers and effector mechanisms10.1155/2015/816460 ↗